4-(2-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)propan-2-yl)phenethyl 4-methylbenzenesulfonate

医药中间体 · — · —

医药中间体Confidentiality：公开

INN / Generic Name: 4-(2-(4,4-Dimethyl-4,5-dihydrooxazol-2-yl)propan-2-yl)phenethyl 4-methylbenzenesulfonate
CAS No.: 202189-76-2
Dosage Form: —
Strength: —
Therapy Area: Pharmaceutical Intermediates
Indication: API: Bilastine
Current Status: 官方中间体目录（API: Bilastine）
GMP Certification: —
CEP: No
DMF Type: —
Stability Data: —
BE Required: Not required / waivable
Registration Pathway: FSO 供货（非注册物质）
MOQ: 询价
Lead Time: 询价
Price Range: 询价

Registrable Markets

Global

Process / Sequence / Exact Price